🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Congratulations to Alok Khorana, MD for winning the oncology #TeacherOfTheYear award. From the #hematology #oncology #fellows Cleveland Clinic MD #CleClinicCancer Cleveland Clinic

Can an electronic health record tool be used for screening and detecting ambulatory #cancer patients at risk of #VTE? Read the new #RPTH study by Girish KunapareddyMD Alok Khorana, MD and colleagues: onlinelibrary.wiley.com/doi/full/10.10…

We found that an automated risk calculator (with a built-in order system) using the Khorana score can detect (>12%) subclinical #DVT in #Cancer clinics. Automated alert also found a high # of patients developed symptomatic #VTE after missed opportunity for screening RPTH

#ICYMI: Study by Girish KunapareddyMD Alok Khorana, MD et al demonstrates the feasibility of an electronic alert tool based on Khorana score to screen & identify ambulatory cancer patients with increased risk of #VTE. Read in #RPTH: onlinelibrary.wiley.com/doi/full/10.10…

Keynote 426 study published in NEJM. Lead author Brian Rini, MD !!

Reducing Time-to-Treat for New Cancer Patients #Matters #PatientsFirst ⁦#GreatWork by leaders ⁦Alok Khorana, MD⁩ ⁦Brian J. Bolwell, MD⁩ ⁦Cleveland Clinic⁩ catalyst.nejm.org/time-to-treatm…

Excited to report CASSINI is now in NEJM Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer | NEJM nejm.org/doi/full/10.10…

Practice changing study— CASSINI trial — lead author Alok Khorana, MD in NEJM today!!

How organizing into different multidisciplinary cancer program teams reduced time-to-treatment for newly diagnosed patients by 33%, increased recognition of patient preferences, and improved clinical alignment: buff.ly/2DF3ZMj Alok Khorana, MD Brian J. Bolwell, MD #CleClinicCancer

Microsatellite-Stable Tumors with High Mutational Burden Benefit from Immunotherapy. - PubMed - Goodman ncbi.nlm.nih.gov/pubmed/3140594…

Cancer associated VTE is a significant problem with 20% of patients with #cancer diagnosed with #VTE. To help improve patient outcomes, we're excited to share a new app by ITAC containing comprehensive clinical practice guidelines published in 2019: apps.apple.com/ca/app/interna…

Walking vs. running: what's better for burning calories? cle.clinic/2NHf8mg

Great showing by the #CleClinicCancer fellows Cleveland Clinic MD at #ASH17 with 4 Oral abstracts and 13 posters Hetty Carraway. Expecting bigger/better SD #ASH18

Great weekend #ASH17 with the Clev Clinic Fellows, and a great party hosted by Sylvester Comprehensive Cancer Center

#ASH17 #Yuuge success. Sagar Patel, MD here for scale. #medhumor #CostEffectivePosterCare

Our work to decrease hospitalizations and #readmissions by creating individualized care plans by collaborative efforts of an #interdisciplinary team, presented at #ASH17 . Cleveland Clinic MD #clecliniccancer #qualityimprovement x.com/cure_magazine/…

Our work to predict recurrent unplanned 30 day readmissions x.com/cancernetwrk/s…

Researchers have found a biomarker for cancer-related recurrent venous thromboembolism: cle.clinic/2gQR4PD

Only about 60 hrs left to submit your #qualityimprovement or #patientsafety abstract to the first annual Cleveland Clinic #patientsafetyday. Hoping for a great showing from all CCF providers #interdisciplinarycare #patients #patientcare #worldclasscare #collaboration Cleveland Clinic MD